Brief: Idera Pharmaceuticals Inc Receives Nasdaq Notice For Not Being Compliant With The Minimum Bid Price Requirement
23/11/2022 21:35
Nov 23 (Reuters) - Idera Pharmaceuticals Inc IDRA.O :
* IDERA PHARMACEUTICALS INC - ON NOVEMBER 22, CO RECEIVED
NOTICE
FROM NASDAQ THAT CO IS NOT BEEN COMPLIANCE WITH THE MINIMUM BID
PRICE REQUIREMENT
Source: (shorturl.at/agT07)
Further company coverage: IDRA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aceragen
See all newsBrief: Aceragen CEO John Taylor's Employment With Co Terminated
Brief: Aceragen Inc To Delist From The Nasdaq Stock Market
Aceragen Inc expected to post a loss of $1.20 a share - Earnings Preview
Brief: Aceragen Board Determined It Is In Best Interests Of Co,To Effect Transfer,Assignment Of All Of Co's Assets To Assignee
Aceragen Inc reports results for the quarter ended in March - Earnings Summary